🇺🇸 FDA
Patent

US 10689352

Solid state forms of trisodium valsartan: sacubitril

granted A61PA61P9/04A61P9/12

Quick answer

US patent 10689352 (Solid state forms of trisodium valsartan: sacubitril) held by TEVA PHARMACEUTICALS INTERNATIONAL GMBH expires Mon Jun 18 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
TEVA PHARMACEUTICALS INTERNATIONAL GMBH
Grant date
Tue Jun 23 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 18 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61P, A61P9/04, A61P9/12